Dachaigh › Cancer Pancreatic › Oklahoma › Oklahoma City
Sgrùdaidhean clionaigeach Cancer Pancreatic ann an Oklahoma City, OK
Tha aon sgrùdadh airson Cancer Pancreatic a’ lorg phàirtichean aig làrach ann no faisg air Oklahoma City. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
The Vanguard Study: Testing a New Way to Screen for Cancer
A’ fastadhFàilte do shaor-thoilich fhallain
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A’ fastadhÌre 3
- Mercy Hospital Oklahoma City - Mercy Coletta Cancer Center - Oklahoma City, Oklahoma City
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
A’ fastadhÌre 1/2
- Stephenson Cancer Center, Oklahoma City
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A’ fastadhÌre 1/2
- University of Oklahoma, Oklahoma City
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
A’ fastadhSgrùdadh amharc
- University of Oklahoma Health Sciences Center, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
A’ fastadhÌre 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
A’ fastadhÌre 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
A’ fastadhÌre 2
- Hightower Clinical, Oklahoma City
ctDNA Assay in Patients With Resectable Pancreatic Cancer
A’ fastadhSgrùdadh amharc
- University of Oklahoma, Oklahoma City
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
A’ fastadhÌre 2
- Ohio State University-Telemedicine, Oklahoma City
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
A’ fastadhÌre 1
- Exelixis Clinical Site #13, Oklahoma City
Sgrùdaidhean Cancer Pancreatic ann am bailtean eile
- Houston, TX61 sgrùdaidhean
- New York City, NY60 sgrùdaidhean
- Boston, MA43 sgrùdaidhean
- Nashville, TN39 sgrùdaidhean
- Los Angeles, CA35 sgrùdaidhean
- St. Louis, MO33 sgrùdaidhean
- Arlington, VA33 sgrùdaidhean
- Baltimore, MD31 sgrùdaidhean
- San Antonio, TX31 sgrùdaidhean
- Philadelphia, PA26 sgrùdaidhean
- Tampa, FL26 sgrùdaidhean
- Durham, NC24 sgrùdaidhean
Sgrùdaidhean eile ann an Oklahoma City
- Aillse Sgamhain Neo-chealla-beag28 sgrùdaidhean
- Cancer Ovarian28 sgrùdaidhean
- Ailse Endometrial25 sgrùdaidhean
- Aillse colorectal22 sgrùdaidhean
- Aillse Prostata21 sgrùdaidhean
- Ailseachadh nan Sgamhan19 sgrùdaidhean
- Aillse a' bhroilleach17 sgrùdaidhean
- Ailse metastatach16 sgrùdaidhean
- Aillse (gach seòrsa)14 sgrùdaidhean
- Leukemia myeloid geur14 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil13 sgrùdaidhean
- Aillse sa bhlaire11 sgrùdadh
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.